- Home
- BDJ vs ANIP Comparison
BDJ vs ANIP Comparison
Compare BDJ & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDJ
- ANIP
- Stock Information
- Founded
- BDJ 2005
- ANIP 2001
- Country
- BDJ United States
- ANIP United States
- Employees
- BDJ N/A
- ANIP N/A
- Industry
- BDJ Finance Companies
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- BDJ Finance
- ANIP Health Care
- Exchange
- BDJ Nasdaq
- ANIP Nasdaq
- Market Cap
- BDJ 1.5B
- ANIP 1.2B
- IPO Year
- BDJ N/A
- ANIP N/A
- Fundamental
- Price
- BDJ $8.63
- ANIP $67.61
- Analyst Decision
- BDJ
- ANIP Strong Buy
- Analyst Count
- BDJ 0
- ANIP 8
- Target Price
- BDJ N/A
- ANIP $79.75
- AVG Volume (30 Days)
- BDJ 561.6K
- ANIP 374.9K
- Earning Date
- BDJ 01-01-0001
- ANIP 05-09-2025
- Dividend Yield
- BDJ 8.85%
- ANIP N/A
- EPS Growth
- BDJ N/A
- ANIP N/A
- EPS
- BDJ N/A
- ANIP N/A
- Revenue
- BDJ N/A
- ANIP $614,376,000.00
- Revenue This Year
- BDJ N/A
- ANIP $26.80
- Revenue Next Year
- BDJ N/A
- ANIP $6.89
- P/E Ratio
- BDJ N/A
- ANIP N/A
- Revenue Growth
- BDJ N/A
- ANIP 26.20
- 52 Week Low
- BDJ $6.91
- ANIP $52.50
- 52 Week High
- BDJ $8.66
- ANIP $70.00
- Technical
- Relative Strength Index (RSI)
- BDJ 45.25
- ANIP 66.47
- Support Level
- BDJ $8.55
- ANIP $62.96
- Resistance Level
- BDJ $8.78
- ANIP $69.33
- Average True Range (ATR)
- BDJ 0.11
- ANIP 2.38
- MACD
- BDJ 0.00
- ANIP 0.46
- Stochastic Oscillator
- BDJ 46.43
- ANIP 85.19
About BDJ Blackrock Enhanced Equity Dividend Trust
BlackRock Enhanced Equity Dividend Trust is a United States closed-end management investment company. Its investment objective is to seek current income and current gains, with a secondary objective of long-term capital appreciation.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.